{ "schemaVersion": 1, "organisationId": "O-a4defd86292e43119a9ded0ee57ce0e9", "slug": "bayer", "name": "BAYER", "updatedAt": "2026-03-20T05:22:27.360928Z", "sections": [ { "type": "OVERVIEW", "text": "Bayer AG is a Leverkusen, Germany-based life science company focused on health and nutrition, with three core businesses: Crop Science, Pharmaceuticals and Consumer Health.[P-446452fa82204dc1ad9d2e7952ecd2cd][P-0e5fff8b787d48e88901dc89910dba67][P-24a4e93708ad4db7bcacce4af3bc4071][P-a15d22022f9943a28968ebd87a4046dc][P-9696128a0a12469cad468fed11d2aab2] These businesses span agricultural inputs such as seeds, traits, crop protection and digital farming tools; prescription medicines in areas including cardiology, women’s health, oncology, hematology, ophthalmology and cell and gene therapy; and over-the-counter self-care products such as nutritional supplements, allergy and cold remedies, dermatology, pain and digestive health products.[P-24a4e93708ad4db7bcacce4af3bc4071][P-a15d22022f9943a28968ebd87a4046dc][P-9696128a0a12469cad468fed11d2aab2]\n\nBayer states its mission as “Health for all, Hunger for none,” reflecting its positioning across healthcare and agriculture.[P-5fe469e18c8e4392bb0582f384c6c349][P-0e5fff8b787d48e88901dc89910dba67] The group has a global footprint with consolidated companies in approximately 80 countries and sales across Europe/Middle East/Africa, North America, Asia/Pacific and Latin America, with North America the largest regional market in 2024.[P-c579f077862c4e9dac3d1c1b98d8d23a][P-ddea90c9ddea4877853f458afaad0325][T-d298e200df65460c8f5fe2ea9fd2e414] In 2024, Bayer reported sales of €46.6 billion and 92,815 employees worldwide.[T-3dbbc134cb1d4591af03f7039eea9340]\n[P-446452fa82204dc1ad9d2e7952ecd2cd][P-0e5fff8b787d48e88901dc89910dba67][P-24a4e93708ad4db7bcacce4af3bc4071][P-a15d22022f9943a28968ebd87a4046dc][P-9696128a0a12469cad468fed11d2aab2][P-5fe469e18c8e4392bb0582f384c6c349][P-c579f077862c4e9dac3d1c1b98d8d23a][P-ddea90c9ddea4877853f458afaad0325][T-d298e200df65460c8f5fe2ea9fd2e414][T-3dbbc134cb1d4591af03f7039eea9340]", "updatedAt": "2026-03-20T05:22:27.360928Z" }, { "type": "PRODUCTS", "text": "Bayer’s product portfolio spans agricultural inputs, prescription medicines and consumer health brands. In Crop Science, the company sells corn seed and trait brands such as DEKALB, RIB Complete, SmartStax, Vitala, VT Double PRO, VT Triple PRO and VTPRO4; soybean seed and trait brands including Asgrow, Intacta RR2PRO, Intacta 2 Xtend, Monsoy and XtendFlex; cotton products including Bollgard 3 XtendFlex, Deltapine and Thryvon; and vegetable seeds under DeRuiter and Seminis. Its crop-protection range includes herbicides such as Adengo, Alion, Atlantis, Conviso, Harness, Laudis, Roundup and Sakura, fungicides including Iblon, Luna, Nativo, Prosaro, Serenade and Xpro, and insecticides such as Confidor, Movento, Sivanto, Vayego and Velum/Verango; the company describes these as biological and chemical solutions for weed, fungal and insect control, with targeted solutions and new modes of action.[P-d7260bdeed3141a4bb922e5427af9dde][T-bbeb849da49c4bc9b842df3a21ae0c6d][P-7f7cabf2c0c14abbb84c7b5e2b643400] Bayer also offers digital agriculture services through Climate FieldView and ForGround. Climate FieldView is described as a digital farming platform for data collection, agronomic insights, product-performance transparency, predictive models and custom recommendations, while the plug-and-play FieldView Drive 2.0 captures equipment data across planting, spraying and harvesting.[T-bbeb849da49c4bc9b842df3a21ae0c6d][P-687c2bb4e31e49c5ad046ad73234e9fe][P-e7c3e8af62604049bdc1e3fa8a5d52fc] In 2024, Crop Science sales were led by Corn Seed & Traits at 29.5% of divisional sales, Herbicides at 24.6%, Fungicides at 14.2%, Soybean Seed & Traits at 11.1% and Insecticides at 7.4%.[T-adf88e1689904424ac84e90f5cb7a69e]\n\nIn Pharmaceuticals, Bayer’s named products include Xarelto, Eylea, Nubeqa, Kerendia, Mirena/Kyleena/Jaydess, Adalat, Aspirin Cardio, Ultravist and CT Fluid Delivery systems in the Stellant family.[P-4e85a6d752c046d0918181ba9c7a1bac][P-84c8de6fa4204ef3aedb3df97139ee80][P-53e1bb5348694fb39f707eccb678cc56][P-8099f640913b4d41970d5e42794f68e3] Eylea 8 mg is indicated for wet age-related macular degeneration and diabetic macular edema, with EU approval supporting treatment intervals of up to five months; Bayer also markets an Eylea 8 mg pre-filled syringe containing 114.3 mg/ml solution for injection and the OcuClick administration device.[P-1735c322e29e4fee805d8f96ed82deda][P-e270d43d693245758331b21b073c4820][P-64451329b1cf4c25af1f5c629ff08ab4] Nubeqa is darolutamide, an oral androgen receptor inhibitor, Kerendia is finerenone for chronic kidney disease associated with type 2 diabetes, Adalat is used for hypertension and coronary heart disease, and Aspirin Cardio is used for secondary prevention of heart attacks.[P-ee51d3713af74bfdb8a9342501b6406d][P-7640fa6adb334df6979fd1dd101fe552][P-6ba2927a23524cc0856e253a98150a45][P-8099f640913b4d41970d5e42794f68e3] Bayer’s top 15 pharmaceutical products accounted for about 85% of Pharmaceuticals sales in 2024, led by Xarelto at 19.2%, Eylea at 18.2%, Nubeqa at 8.4% and Mirena/Kyleena/Jaydess at 7.0%.[T-f1e22f2eb037401f89674aaac662528d]\n\nIn Consumer Health, Bayer’s product lineup includes over-the-counter brands across nutritionals, allergy and cold, dermatology, pain/cardio and digestive health. Recent examples cited include Alka-Seltzer Plus in the United States in a fizzy melt format for digestive relief and a fizzy chew for cough and cold, Iberogast in the United States, IberoFlora as a probiotic for kids in Mexico, the Bepanthen skin-care line in India, Saridon for women’s pain relief and Canesten Lactic Acid Vagina Gel in China.[P-a12ea19122dd4eee9231a24702ea87fe][P-f9464f3e50644de4b544dd5a87a3ca55][P-1ab723482345480f938f236617528340] Other consumer brands specifically highlighted include Supradyn in nutritionals, Actron in pain and cardio, and KangWang in dermatology.[P-4843c514bf6f441e88a20e125bdd63b0][P-bda44123efae4ba4a10184b9d2f1c876][P-e75617c07a0d4f1a92ad2fa53cbc15c8]\n[P-d7260bdeed3141a4bb922e5427af9dde][T-bbeb849da49c4bc9b842df3a21ae0c6d][P-7f7cabf2c0c14abbb84c7b5e2b643400][P-687c2bb4e31e49c5ad046ad73234e9fe][P-e7c3e8af62604049bdc1e3fa8a5d52fc][T-adf88e1689904424ac84e90f5cb7a69e][P-4e85a6d752c046d0918181ba9c7a1bac][P-84c8de6fa4204ef3aedb3df97139ee80][P-53e1bb5348694fb39f707eccb678cc56][P-8099f640913b4d41970d5e42794f68e3][P-1735c322e29e4fee805d8f96ed82deda][P-e270d43d693245758331b21b073c4820][P-64451329b1cf4c25af1f5c629ff08ab4][P-ee51d3713af74bfdb8a9342501b6406d][P-7640fa6adb334df6979fd1dd101fe552][P-6ba2927a23524cc0856e253a98150a45][T-f1e22f2eb037401f89674aaac662528d][P-a12ea19122dd4eee9231a24702ea87fe][P-f9464f3e50644de4b544dd5a87a3ca55][P-1ab723482345480f938f236617528340][P-4843c514bf6f441e88a20e125bdd63b0][P-bda44123efae4ba4a10184b9d2f1c876][P-e75617c07a0d4f1a92ad2fa53cbc15c8]", "updatedAt": "2026-03-20T05:22:27.360928Z" }, { "type": "GEOGRAPHY", "text": "Bayer is headquartered in Leverkusen, Germany, and at year-end 2024 the group comprised 291 consolidated companies in approximately 80 countries. Its listed administrative sites include Leverkusen, Monheim am Rhein and Berlin in Germany, Basel in Switzerland, and St. Louis in the United States [P-dbd545c905aa4e03aa576bfb913b34a6][P-c579f077862c4e9dac3d1c1b98d8d23a].\n\nThe company reports sales across four main regions: Europe/Middle East/Africa (EMEA), North America, Asia/Pacific, and Latin America [P-9fe20e341f944f8992cc245423c16850][T-d298e200df65460c8f5fe2ea9fd2e414]. In 2024, Bayer generated €46.6 billion of sales, of which North America contributed €16.5 billion (about 35%), EMEA €14.0 billion (about 30%), Asia/Pacific €8.1 billion (about 17%), and Latin America €8.1 billion (about 17%) [T-d298e200df65460c8f5fe2ea9fd2e414]. The same disclosure highlights important country markets within those regions, including the United States at €14.8 billion, Brazil at €4.3 billion, China at €3.6 billion, Germany at €2.4 billion, and Switzerland at €0.6 billion of 2024 sales [T-d298e200df65460c8f5fe2ea9fd2e414].\n\nBayer’s workforce is also geographically concentrated in these regions. Total headcount was 94,081 at the end of 2024, and Bayer identifies Germany and the United States as its only countries with significant employment; headcount in those countries was 21,824 and 17,697, respectively [P-8a3419779ac4484eb91bf369ded764da][P-6a093ba9939046778092021670a41036][T-0a064854963b407fa2a869a8e1929329]. A regional employee table shows 42,334 employees in EMEA, 19,205 in North America, 12,994 in Latin America, and 19,548 in Asia/Pacific [P-63badc6937c14accade331a937a6de58][T-637e4276f30346d4a1a4678a27f04db5].\n\nIts operational footprint spans Europe, North America, Latin America, and Asia through research, development, and production sites. Examples named by the company include R&D locations in Chesterfield, Missouri; Lyon; Monheim am Rhein; Berlin; Whippany, New Jersey; Wuppertal; Basel; and Gaillard, and production sites in Dormagen, Luling, Vapi, Bergkamen, Berlin, Leverkusen, Grenzach, Lerma, and Myerstown [P-3ee03b27cb12476a9ba415efd003774e][P-0651b53a73c5462eba9c8619bf433e7e][P-ebd530fa266d4fe0a4857d25375ad513][P-6e2b5f2742724a7187e36f0779cf6fd8][P-92c60dd7f9c0404eaf9e2b21dc623aeb][P-7dd605e494c141bca86a2501e258f614].\n[P-dbd545c905aa4e03aa576bfb913b34a6][P-c579f077862c4e9dac3d1c1b98d8d23a][P-9fe20e341f944f8992cc245423c16850][T-d298e200df65460c8f5fe2ea9fd2e414][P-8a3419779ac4484eb91bf369ded764da][P-6a093ba9939046778092021670a41036][T-0a064854963b407fa2a869a8e1929329][P-63badc6937c14accade331a937a6de58][T-637e4276f30346d4a1a4678a27f04db5][P-3ee03b27cb12476a9ba415efd003774e][P-0651b53a73c5462eba9c8619bf433e7e][P-ebd530fa266d4fe0a4857d25375ad513][P-6e2b5f2742724a7187e36f0779cf6fd8][P-92c60dd7f9c0404eaf9e2b21dc623aeb][P-7dd605e494c141bca86a2501e258f614]", "updatedAt": "2026-03-20T05:22:27.360928Z" }, { "type": "SEGMENTS", "text": "Bayer reports three operating divisions: Crop Science, Pharmaceuticals, and Consumer Health, with enabling functions supporting them.[P-cfd64862000f4e5ba11a01968bb6270c] Crop Science is focused on crop protection, seeds and traits, digital solutions, and customer services for sustainable agriculture.[P-24a4e93708ad4db7bcacce4af3bc4071] Pharmaceuticals comprises prescription medicines, with core areas including cardiology, women’s healthcare, oncology, hematology, ophthalmology, cell and gene therapy, and radiology.[P-a15d22022f9943a28968ebd87a4046dc] Consumer Health covers nonprescription self-care products, including nutritional supplements, allergy, cough and cold, dermatology, pain/cardiovascular risk prevention, and digestive health.[P-9696128a0a12469cad468fed11d2aab2]\n\nUsing Bayer’s 2024 reported sales, Crop Science was the largest segment at €22.259 billion, or about 47.8% of group sales.[P-239188139334427292ddc06aded67a39][P-fbea5d6d5b8349188ab42316ece9e021] Pharmaceuticals contributed €18.131 billion, or about 38.9%.[P-239188139334427292ddc06aded67a39][P-fbea5d6d5b8349188ab42316ece9e021] Consumer Health contributed €5.870 billion, or about 12.6%.[P-239188139334427292ddc06aded67a39][P-fbea5d6d5b8349188ab42316ece9e021] Bayer’s reported segment table also includes a small reconciliation line of €346 million, equal to roughly 0.7% of group sales.[P-239188139334427292ddc06aded67a39][P-fbea5d6d5b8349188ab42316ece9e021]\n[P-cfd64862000f4e5ba11a01968bb6270c][P-24a4e93708ad4db7bcacce4af3bc4071][P-a15d22022f9943a28968ebd87a4046dc][P-9696128a0a12469cad468fed11d2aab2][P-239188139334427292ddc06aded67a39][P-fbea5d6d5b8349188ab42316ece9e021]", "updatedAt": "2026-03-20T05:22:27.360928Z" }, { "type": "HISTORY", "text": "Bayer was founded on August 1, 1863, in Wuppertal-Barmen by Friedrich Bayer and Johann Friedrich Weskott.[https://www.bayer.com/en/history/history][https://www.bayer.com/en/history/1863-1881] In 1881, it was converted into a joint-stock company under the name Farbenfabriken vorm. Friedr. Bayer & Co., an early step in its industrial expansion.[https://www.bayer.com/en/history/1881-1914] A major pharmaceutical milestone followed when Felix Hoffmann synthesized a stable form of acetylsalicylic acid in 1897, and Aspirin was trademarked and launched in 1899.[https://www.aspirin.bayer.com/en/about-aspirin/history/][https://www.bayer.com/en/history/felix-hoffmann]\n\nIn 1925, Bayer became part of IG Farben; after World War II and the breakup of that conglomerate, Bayer was reestablished in the early 1950s and rebuilt its international business.[https://www.bayer.com/en/history/1925-1945][https://www.bayer.com/en/history/1945-1951][https://www.bayer.com/en/history/1951-1974] At the start of the 2000s, Bayer reshaped the group through acquisitions and reorganization, buying Aventis CropScience in 2001 and launching Bayer CropScience as a legally independent subgroup in 2002.[https://www.bayer.com/en/history/2001-2010] In 2006, it acquired Schering, significantly expanding its pharmaceuticals operations.[https://www.sec.gov/Archives/edgar/data/1144145/000104746906003897/a2168750zex-99_2.htm][https://www.bayer.com/en/history/2001-2010] In the 2010s, Bayer separated its materials-science business as Covestro and then completed the acquisition of Monsanto in 2018, another major turning point in the company’s development.[https://www.bayer.com/en/history/2010-2022][https://www.bayer.com/media/en-us/bayer-closes-monsanto-acquisition/]\n[https://www.bayer.com/en/history/history][https://www.bayer.com/en/history/1863-1881][https://www.bayer.com/en/history/1881-1914][https://www.aspirin.bayer.com/en/about-aspirin/history/][https://www.bayer.com/en/history/felix-hoffmann][https://www.bayer.com/en/history/1925-1945][https://www.bayer.com/en/history/1945-1951][https://www.bayer.com/en/history/1951-1974][https://www.bayer.com/en/history/2001-2010][https://www.sec.gov/Archives/edgar/data/1144145/000104746906003897/a2168750zex-99_2.htm][https://www.bayer.com/en/history/2010-2022][https://www.bayer.com/media/en-us/bayer-closes-monsanto-acquisition/]", "updatedAt": "2026-03-20T05:22:27.360928Z" } ], "sources": [ { "id": "P-446452fa82204dc1ad9d2e7952ecd2cd", "href": "https://app.finbar.com/go?id=P-446452fa82204dc1ad9d2e7952ecd2cd", "label": "BAYER — Full financial report (2024 Y), p261", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 261 }, { "id": "P-0e5fff8b787d48e88901dc89910dba67", "href": "https://app.finbar.com/go?id=P-0e5fff8b787d48e88901dc89910dba67", "label": "BAYER — Full financial report (2024 Y), p28", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 28 }, { "id": "P-24a4e93708ad4db7bcacce4af3bc4071", "href": "https://app.finbar.com/go?id=P-24a4e93708ad4db7bcacce4af3bc4071", "label": "BAYER — Full financial report (2024 Y), p29", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 29 }, { "id": "P-a15d22022f9943a28968ebd87a4046dc", "href": "https://app.finbar.com/go?id=P-a15d22022f9943a28968ebd87a4046dc", "label": "BAYER — Full financial report (2024 Y), p29", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 29 }, { "id": "P-9696128a0a12469cad468fed11d2aab2", "href": "https://app.finbar.com/go?id=P-9696128a0a12469cad468fed11d2aab2", "label": "BAYER — Full financial report (2024 Y), p29", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 29 }, { "id": "P-5fe469e18c8e4392bb0582f384c6c349", "href": "https://app.finbar.com/go?id=P-5fe469e18c8e4392bb0582f384c6c349", "label": "BAYER — Full financial report (2024 Y), p28", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 28 }, { "id": "P-c579f077862c4e9dac3d1c1b98d8d23a", "href": "https://app.finbar.com/go?id=P-c579f077862c4e9dac3d1c1b98d8d23a", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-ddea90c9ddea4877853f458afaad0325", "href": "https://app.finbar.com/go?id=P-ddea90c9ddea4877853f458afaad0325", "label": "BAYER — Full financial report (2024 Y), p282", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 282 }, { "id": "T-d298e200df65460c8f5fe2ea9fd2e414", "href": "https://app.finbar.com/go?id=T-d298e200df65460c8f5fe2ea9fd2e414", "label": "BAYER — Full financial report (2024 Y), p282", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 282 }, { "id": "T-3dbbc134cb1d4591af03f7039eea9340", "href": "https://app.finbar.com/go?id=T-3dbbc134cb1d4591af03f7039eea9340", "label": "BAYER — Full financial report (2024 Y), p2", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 2 }, { "id": "P-d7260bdeed3141a4bb922e5427af9dde", "href": "https://app.finbar.com/go?id=P-d7260bdeed3141a4bb922e5427af9dde", "label": "BAYER — Full financial report (2024 Y), p29", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 29 }, { "id": "T-bbeb849da49c4bc9b842df3a21ae0c6d", "href": "https://app.finbar.com/go?id=T-bbeb849da49c4bc9b842df3a21ae0c6d", "label": "BAYER — Full financial report (2024 Y), p30", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 30 }, { "id": "P-7f7cabf2c0c14abbb84c7b5e2b643400", "href": "https://app.finbar.com/go?id=P-7f7cabf2c0c14abbb84c7b5e2b643400", "label": "BAYER — Full financial report (2024 Y), p39", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 39 }, { "id": "P-687c2bb4e31e49c5ad046ad73234e9fe", "href": "https://app.finbar.com/go?id=P-687c2bb4e31e49c5ad046ad73234e9fe", "label": "BAYER — Full financial report (2024 Y), p39", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 39 }, { "id": "P-e7c3e8af62604049bdc1e3fa8a5d52fc", "href": "https://app.finbar.com/go?id=P-e7c3e8af62604049bdc1e3fa8a5d52fc", "label": "BAYER — Full financial report (2024 Y), p41", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 41 }, { "id": "T-adf88e1689904424ac84e90f5cb7a69e", "href": "https://app.finbar.com/go?id=T-adf88e1689904424ac84e90f5cb7a69e", "label": "BAYER — Full financial report (2024 Y), p63", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 63 }, { "id": "P-4e85a6d752c046d0918181ba9c7a1bac", "href": "https://app.finbar.com/go?id=P-4e85a6d752c046d0918181ba9c7a1bac", "label": "BAYER — Full financial report (2024 Y), p66", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 66 }, { "id": "P-84c8de6fa4204ef3aedb3df97139ee80", "href": "https://app.finbar.com/go?id=P-84c8de6fa4204ef3aedb3df97139ee80", "label": "BAYER — Full financial report (2024 Y), p67", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 67 }, { "id": "P-53e1bb5348694fb39f707eccb678cc56", "href": "https://app.finbar.com/go?id=P-53e1bb5348694fb39f707eccb678cc56", "label": "BAYER — Full financial report (2024 Y), p66", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 66 }, { "id": "P-8099f640913b4d41970d5e42794f68e3", "href": "https://app.finbar.com/go?id=P-8099f640913b4d41970d5e42794f68e3", "label": "BAYER — Full financial report (2024 Y), p66", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 66 }, { "id": "P-1735c322e29e4fee805d8f96ed82deda", "href": "https://app.finbar.com/go?id=P-1735c322e29e4fee805d8f96ed82deda", "label": "BAYER — Full financial report (2024 Y), p49", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 49 }, { "id": "P-e270d43d693245758331b21b073c4820", "href": "https://app.finbar.com/go?id=P-e270d43d693245758331b21b073c4820", "label": "BAYER — Full financial report (2024 Y), p55", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 55 }, { "id": "P-64451329b1cf4c25af1f5c629ff08ab4", "href": "https://app.finbar.com/go?id=P-64451329b1cf4c25af1f5c629ff08ab4", "label": "BAYER — Full financial report (2024 Y), p49", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 49 }, { "id": "P-ee51d3713af74bfdb8a9342501b6406d", "href": "https://app.finbar.com/go?id=P-ee51d3713af74bfdb8a9342501b6406d", "label": "BAYER — Full financial report (2024 Y), p55", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 55 }, { "id": "P-7640fa6adb334df6979fd1dd101fe552", "href": "https://app.finbar.com/go?id=P-7640fa6adb334df6979fd1dd101fe552", "label": "BAYER — Full financial report (2024 Y), p55", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 55 }, { "id": "P-6ba2927a23524cc0856e253a98150a45", "href": "https://app.finbar.com/go?id=P-6ba2927a23524cc0856e253a98150a45", "label": "BAYER — Full financial report (2024 Y), p66", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 66 }, { "id": "T-f1e22f2eb037401f89674aaac662528d", "href": "https://app.finbar.com/go?id=T-f1e22f2eb037401f89674aaac662528d", "label": "BAYER — Full financial report (2024 Y), p66", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 66 }, { "id": "P-a12ea19122dd4eee9231a24702ea87fe", "href": "https://app.finbar.com/go?id=P-a12ea19122dd4eee9231a24702ea87fe", "label": "BAYER — Full financial report (2024 Y), p9", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 9 }, { "id": "P-f9464f3e50644de4b544dd5a87a3ca55", "href": "https://app.finbar.com/go?id=P-f9464f3e50644de4b544dd5a87a3ca55", "label": "BAYER — Full financial report (2024 Y), p53", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 53 }, { "id": "P-1ab723482345480f938f236617528340", "href": "https://app.finbar.com/go?id=P-1ab723482345480f938f236617528340", "label": "BAYER — Full financial report (2024 Y), p53", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 53 }, { "id": "P-4843c514bf6f441e88a20e125bdd63b0", "href": "https://app.finbar.com/go?id=P-4843c514bf6f441e88a20e125bdd63b0", "label": "BAYER — Full financial report (2024 Y), p69", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 69 }, { "id": "P-bda44123efae4ba4a10184b9d2f1c876", "href": "https://app.finbar.com/go?id=P-bda44123efae4ba4a10184b9d2f1c876", "label": "BAYER — Full financial report (2024 Y), p69", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 69 }, { "id": "P-e75617c07a0d4f1a92ad2fa53cbc15c8", "href": "https://app.finbar.com/go?id=P-e75617c07a0d4f1a92ad2fa53cbc15c8", "label": "BAYER — Full financial report (2024 Y), p69", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 69 }, { "id": "P-dbd545c905aa4e03aa576bfb913b34a6", "href": "https://app.finbar.com/go?id=P-dbd545c905aa4e03aa576bfb913b34a6", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-9fe20e341f944f8992cc245423c16850", "href": "https://app.finbar.com/go?id=P-9fe20e341f944f8992cc245423c16850", "label": "BAYER — Full financial report (2024 Y), p282", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 282 }, { "id": "P-8a3419779ac4484eb91bf369ded764da", "href": "https://app.finbar.com/go?id=P-8a3419779ac4484eb91bf369ded764da", "label": "BAYER — Full financial report (2024 Y), p195", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 195 }, { "id": "P-6a093ba9939046778092021670a41036", "href": "https://app.finbar.com/go?id=P-6a093ba9939046778092021670a41036", "label": "BAYER — Full financial report (2024 Y), p195", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 195 }, { "id": "T-0a064854963b407fa2a869a8e1929329", "href": "https://app.finbar.com/go?id=T-0a064854963b407fa2a869a8e1929329", "label": "BAYER — Full financial report (2024 Y), p195", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 195 }, { "id": "P-63badc6937c14accade331a937a6de58", "href": "https://app.finbar.com/go?id=P-63badc6937c14accade331a937a6de58", "label": "BAYER — Full financial report (2024 Y), p197", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 197 }, { "id": "T-637e4276f30346d4a1a4678a27f04db5", "href": "https://app.finbar.com/go?id=T-637e4276f30346d4a1a4678a27f04db5", "label": "BAYER — Full financial report (2024 Y), p197", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 197 }, { "id": "P-3ee03b27cb12476a9ba415efd003774e", "href": "https://app.finbar.com/go?id=P-3ee03b27cb12476a9ba415efd003774e", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-0651b53a73c5462eba9c8619bf433e7e", "href": "https://app.finbar.com/go?id=P-0651b53a73c5462eba9c8619bf433e7e", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-ebd530fa266d4fe0a4857d25375ad513", "href": "https://app.finbar.com/go?id=P-ebd530fa266d4fe0a4857d25375ad513", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-6e2b5f2742724a7187e36f0779cf6fd8", "href": "https://app.finbar.com/go?id=P-6e2b5f2742724a7187e36f0779cf6fd8", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-92c60dd7f9c0404eaf9e2b21dc623aeb", "href": "https://app.finbar.com/go?id=P-92c60dd7f9c0404eaf9e2b21dc623aeb", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-7dd605e494c141bca86a2501e258f614", "href": "https://app.finbar.com/go?id=P-7dd605e494c141bca86a2501e258f614", "label": "BAYER — Full financial report (2024 Y), p31", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 31 }, { "id": "P-cfd64862000f4e5ba11a01968bb6270c", "href": "https://app.finbar.com/go?id=P-cfd64862000f4e5ba11a01968bb6270c", "label": "BAYER — Full financial report (2024 Y), p28", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 28 }, { "id": "P-239188139334427292ddc06aded67a39", "href": "https://app.finbar.com/go?id=P-239188139334427292ddc06aded67a39", "label": "BAYER — Full financial report (2024 Y), p58", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 58 }, { "id": "P-fbea5d6d5b8349188ab42316ece9e021", "href": "https://app.finbar.com/go?id=P-fbea5d6d5b8349188ab42316ece9e021", "label": "BAYER — Full financial report (2024 Y), p58", "documentId": "D-3b8330f66015434abe5980b1dc74b8d2", "page": 58 }, { "id": "https://www.bayer.com/en/history/history", "href": "https://www.bayer.com/en/history/history", "label": "www.bayer.com" }, { "id": "https://www.bayer.com/en/history/1863-1881", "href": "https://www.bayer.com/en/history/1863-1881", "label": "www.bayer.com" }, { "id": "https://www.bayer.com/en/history/1881-1914", "href": "https://www.bayer.com/en/history/1881-1914", "label": "www.bayer.com" }, { "id": "https://www.aspirin.bayer.com/en/about-aspirin/history/", "href": "https://www.aspirin.bayer.com/en/about-aspirin/history/", "label": "www.aspirin.bayer.com" }, { "id": "https://www.bayer.com/en/history/felix-hoffmann", "href": "https://www.bayer.com/en/history/felix-hoffmann", "label": "www.bayer.com" }, { "id": "https://www.bayer.com/en/history/1925-1945", "href": "https://www.bayer.com/en/history/1925-1945", "label": "www.bayer.com" }, { "id": "https://www.bayer.com/en/history/1945-1951", "href": "https://www.bayer.com/en/history/1945-1951", "label": "www.bayer.com" }, { "id": "https://www.bayer.com/en/history/1951-1974", "href": "https://www.bayer.com/en/history/1951-1974", "label": "www.bayer.com" }, { "id": "https://www.bayer.com/en/history/2001-2010", "href": "https://www.bayer.com/en/history/2001-2010", "label": "www.bayer.com" }, { "id": "https://www.sec.gov/Archives/edgar/data/1144145/000104746906003897/a2168750zex-99_2.htm", "href": "https://www.sec.gov/Archives/edgar/data/1144145/000104746906003897/a2168750zex-99_2.htm", "label": "www.sec.gov" }, { "id": "https://www.bayer.com/en/history/2010-2022", "href": "https://www.bayer.com/en/history/2010-2022", "label": "www.bayer.com" }, { "id": "https://www.bayer.com/media/en-us/bayer-closes-monsanto-acquisition/", "href": "https://www.bayer.com/media/en-us/bayer-closes-monsanto-acquisition/", "label": "www.bayer.com" } ] }